Cite
MLA Citation
Alberto J. Lorenzatti et al.. “Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial.” Diabetes, obesity & metabolism, vol. 21, no. 6, 2019, pp. 1455–1463. http://access.bl.uk/ark:/81055/vdc_100081482956.0x000023